George M Martin (George Martin)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Dermatology and therapy

Journal of cosmetic dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Aditya Kumar Gupta, Mary A Bamimore, Tong Wang, Shruthi Polla Ravi, Sandor Haas-Neil, George M Martin, Vincent Piguet, Mesbah Talukder
Comparison of therapeutic agents' short-term effects on facial and scalp actinic keratosis: A network meta-analysis. Journal of cosmetic dermatology (2024)
Mark G Lebwohl, John Y Koo, April W Armstrong, Bruce E Strober, George M Martin, Nicole N Rawnsley, Earl L Goehring, Abby A Jacobson
Brodalumab: 5-Year US Pharmacovigilance Report. Dermatology and therapy 14 (5) (2024)
Mark G Lebwohl, John Y Koo, April W Armstrong, Bruce E Strober, George M Martin, Nicole N Rawnsley, Earl L Goehring, Abby A Jacobson
Brodalumab: 5-Year US Pharmacovigilance Report. Dermatology and therapy (2024)
Mark G Lebwohl, John Y Koo, April W Armstrong, Bruce E Strober, George M Martin, Nicole N Rawnsley, Earl L Goehring, Abby A Jacobson
Brodalumab: 5-Year US Pharmacovigilance Report. Dermatology and therapy 14 (5) (2024)
Mark G Lebwohl, John Y Koo, April W Armstrong, Bruce E Strober, George M Martin, Nicole N Rawnsley, Earl L Goehring, Abby A Jacobson
Brodalumab: 5-Year US Pharmacovigilance Report. Dermatology and therapy 14 (5) (2024)
George M Martin
Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors. Dermatology and therapy 13 (2) (2023)
George M Martin
Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors. Dermatology and therapy (2023)
George M Martin
Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors. Dermatology and therapy 13 (2) (2023)
George M Martin
Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors. Dermatology and therapy 13 (2) (2023)